NCT04601103

Brief Summary

The primary objective of this study is to evaluate the incidence of oral tissue sloughing through self-report by study subjects and by professional dental examinations.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
53

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 6, 2020

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 10, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 10, 2020

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

October 13, 2020

Completed
10 days until next milestone

First Posted

Study publicly available on registry

October 23, 2020

Completed
1.1 years until next milestone

Results Posted

Study results publicly available

November 19, 2021

Completed
Last Updated

October 1, 2024

Status Verified

September 1, 2024

Enrollment Period

2 months

First QC Date

October 13, 2020

Results QC Date

September 16, 2021

Last Update Submit

September 27, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of Participants With Oral Mucosal Exfoliation (Oral Sloughing)

    Percentage of participants who experienced oral sloughing as reported either by the subject or determined by the dental evaluator.

    End of treatment (3 weeks)

Secondary Outcomes (2)

  • The Number of Participants With a Given Range of Average Oral Mucosal Sloughing Index Scores

    Mid-Treatment (10 days)

  • The Number of Participants With a Given Range of Average Oral Mucosal Sloughing Index Scores.

    End of Treatment (3 weeks)

Other Outcomes (1)

  • The Number of Participants Reporting Their Acceptance Levels of Side Effects

    End of Treatment (3 weeks)

Study Arms (3)

Comparator: No SLS Toothpaste

EXPERIMENTAL

3M Oral Rinse in combination with no SLS toothpaste (A)

Drug: No SLS toothpasteDevice: Anti-plaque

Comparator: Medium SLS Toothpaste

EXPERIMENTAL

3M Oral Rinse in combination with medium SLS toothpaste (B)

Drug: Medium SLS toothpasteDevice: Anti-plaque

Comparator: High SLS Toothpaste

EXPERIMENTAL

3M Oral Rinse in combination with high SLS toothpaste (C)

Drug: High SLS toothpasteDevice: Anti-plaque

Interventions

Toothpaste no Sodium Lauryl Sulfate

Also known as: Sensodyne ProNamel Fresh Breath Toothpaste
Comparator: No SLS Toothpaste

Less than or equal to X ppm Sodium Lauryl Sulfate

Also known as: Clinpro Tooth Creme
Comparator: Medium SLS Toothpaste

More than or equal to X ppm Sodium Lauryl Sulfate

Also known as: Colgate Cavity Protection Toothpaste
Comparator: High SLS Toothpaste

Rinse prevents bacterial adherence to teeth

Also known as: 3M Oral Rinse
Comparator: High SLS ToothpasteComparator: Medium SLS ToothpasteComparator: No SLS Toothpaste

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Able to understand and willing to sign the informed consent;
  • Willing to agree to maintain confidentiality of the study and study materials;
  • M employee aged 18 years and older;
  • Willing to return to the study facility for scheduled study visits and recalls;
  • Agree not to use other oral hygiene products (non-study toothpaste, non-study toothbrush, mouth rinse, chewing gum);
  • Agree to the study instruction and schedule

You may not qualify if:

  • A member of the Medical Clinical Affairs (MCA) staff or Panda product team for the device under investigation;
  • Have a dental appointment scheduled during study duration for professional cleaning;
  • Is pregnant, nursing, or planning to become pregnant within the study duration;
  • History of antibiotic therapy within the previous 30 days or have a condition that is likely to need antibiotic treatment over the course of the study (e.g., cardiac conditions requiring antibiotic prophylaxis such as heart murmurs, pacemakers, or prosthetic heart valves and prosthetic implants);
  • History of using a prescription antimicrobial mouth rinse during the past 3 months;
  • Currently taking medications which may alter gingival appearance/bleeding;
  • Currently using anticonvulsants, calcium channel blockers, or other medications with side effects known to impact oral health;
  • Participation in any other clinical study within the last 30 days;
  • Resides in the same household with a subject already enrolled in the study;
  • Known history of sensitivity to oral hygiene products;
  • Currently using tobacco products (cigarettes, chewing tobacco) or vaping products (ecigarettes);
  • History of diabetes;
  • Have removable partial/full dentures;
  • Have orthodontic appliances;
  • Have medical or oral conditions that may compromise the subject's safety or interfere with the conduct and outcome of the study;
  • +6 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

3M Health Care

Saint Paul, Minnesota, 55144, United States

Location

Limitations and Caveats

The major limitation with this study is that the sample size goal was not reached given the early termination during the washout period of a two-period crossover design.

Results Point of Contact

Title
Brenda Coalwell, Clinical Affairs Manager
Organization
3M Health Care Business Group

Study Officials

  • Brenda C Coalwell, BA

    3M Health Care Business Group

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Assessors did not know what toothpaste subjects used.
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: The study was designed as an imbalanced 2 Period Crossover Study. However, the study was terminated during the washout period and the results reported here reflect only the period 1 results.
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 13, 2020

First Posted

October 23, 2020

Study Start

January 6, 2020

Primary Completion

March 10, 2020

Study Completion

March 10, 2020

Last Updated

October 1, 2024

Results First Posted

November 19, 2021

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

Locations